Grace Link Barnes

Medicine & Life Sciences

1. Tuberculosis 100%
2. Isoniazid 58%
3. HIV 53%
4. rifapentine 41%
5. Rifampin 37%
6. Malawi 28%
7. Pulmonary Tuberculosis 27%
8. pretomanid 26%
9. Tuberculin Test 24%
10. Latent Tuberculosis 21%
11. Pyrazinamide 20%
12. CD4 Lymphocyte Count 20%
13. Skin Tests 19%
14. Meropenem 18%
15. South Africa 16%
16. Therapeutics 15%
17. Pharmacokinetics 13%
18. Virus Diseases 13%
19. Viral Load 13%
20. Acquired Immunodeficiency Syndrome 12%
21. Rifamycins 12%
22. Lesotho 12%
23. Clavulanic Acid 10%
24. Obstructive Lung Diseases 9%
25. Mycobacterium avium Complex 9%
26. Safety 9%
27. Moxifloxacin 9%
28. Clarithromycin 8%
29. rifamycin SV 8%
30. Tuberculin 8%
31. Brazil 7%
32. Population 7%
33. Drug Users 7%
34. Sputum 7%
35. Clinical Trials 7%
36. Interferons 6%
37. Rifabutin 6%
38. Child 6%
39. Microscopy 6%
40. Pharmaceutical Preparations 5%
41. Direction compound 5%
42. Randomized Controlled Trials 5%